Uruguay consolidates its presence on the global biotechnology stage from Boston

Uruguay was present at the BIO International Convention, the leading event for the global biotechnology industry, held in Boston, United States. With more than 20,000 participants from the sector, the 2025 edition of the meeting brought together global leaders from the pharmaceutical industry, Clinical Research Organizations (CDMOs), Contract Manufacturing & Development Organizations (CROs), investors, research centers, and science-based startups to outline the future of life sciences.

The presence of Uruguay XXI, the agency for the promotion of investment, exports, and country image, was coordinated with the participation of three national startups: LocBIO, Guska, and B4RNA. These companies represent the most advanced scientific and entrepreneurial talent in Uruguay, with innovative developments in biotechnology aimed at solving global challenges in health and sustainability.

“In Uruguay, we are experiencing an unprecedented moment in the development of life sciences startups, and we need to continue building bridges to accelerate this growth,” said Nicolás Tambucho, co-founder of Guska, on social media during the event. This vision reflects a growing awareness of Uruguay's potential in a high value-added sector.

Dialogue with authorities and strategic visibility

One of the highlights of the delegation's visit was the meeting with Massachusetts Lieutenant Governor Kim Driscoll. She spoke with representatives of Uruguay XXI and the startups in attendance about opportunities for integrating Uruguayan talent into the dynamic innovation ecosystem of Boston and Cambridge, two global hubs for biotechnology. The conversation addressed possible synergies in areas of common interest such as life sciences, AI, and sustainability.

The Uruguayan delegation also included professionals from the Cervieri Monsuarez law firm and representatives from the Scienza company, which broadened the institutional and corporate reach of the national presence. This diversity of actors helped strengthen the positioning of the Uruguayan ecosystem as a reliable, collaborative environment with an international vision.

The Boston Convention & Exhibition Center, home to BIO 2025, also has special significance for Uruguay. The building was designed by Uruguayan architect Rafael Viñoly, adding a symbolic element and national pride to the country's participation in this high-level forum.

Projection and opportunities

Participation in BIO 2025 is part of a national strategy to integrate into global biotechnology value chains, promoting innovation from a highly competitive country. For Uruguay XXI, this type of event represents a key platform for connecting with international players, showcasing local capabilities, and attracting knowledge-oriented investment.

“Talent, institutional stability, and a commitment to science and innovation position us as an emerging hub in Latin America,” said Cristina Montero, investment attraction specialist for the sector at Uruguay XXI.

Participation in BIO 2025 reflects Uruguay's commitment to becoming increasingly integrated into the global life sciences ecosystem, offering a competitive, stable, and collaborative environment for innovation, scientific development, and investment attraction.